A5051663127- Venous Thromboembolism Diagnosis and Management
- Hemoglobinopathies and Related Disorders
- Central Venous Catheters and Hemodialysis
- Cardiac tumors and thrombi
- Brain Metastases and Treatment
- Atrial Fibrillation Management and Outcomes
- Iron Metabolism and Disorders
- Acute Ischemic Stroke Management
- Lymphoma Diagnosis and Treatment
- Hemophilia Treatment and Research
- Prenatal Screening and Diagnostics
- CNS Lymphoma Diagnosis and Treatment
- Acute Myocardial Infarction Research
- Lung Cancer Diagnosis and Treatment
- Myeloproliferative Neoplasms: Diagnosis and Treatment
- Pregnancy and preeclampsia studies
- Antiplatelet Therapy and Cardiovascular Diseases
- Uterine Myomas and Treatments
- Patient Satisfaction in Healthcare
- Hematological disorders and diagnostics
- Blood transfusion and management
- Cardiac Imaging and Diagnostics
- Food Security and Health in Diverse Populations
- Chemotherapy-induced cardiotoxicity and mitigation
- Healthcare Systems and Reforms
University of California, Davis
2017-2025
UC Davis Comprehensive Cancer Center
2019-2024
University of California Davis Medical Center
2011-2023
University of California, San Francisco
2014-2017
Cancer-associated thrombosis (CAT) is an important cause of morbidity and mortality for patients with malignancy varies by primary cancer type, stage, therapy. We aimed to characterize the incidence, risk factors, temporal trends, effect on CAT. The California Cancer Registry was linked statewide hospitalization database identify individuals 13 most common malignancies diagnosed between 2005 2017 determine 6- 12-month cumulative incidence CAT venous thromboembolism (VTE) location, tumor...
The NCCN Guidelines for Hematopoietic Growth Factors provide recommendations the appropriate use of growth factors in clinical management febrile neutropenia (FN), chemotherapy-induced thrombocytopenia (CIT), and anemia (CIA). Management prevention these sequelae are an integral part supportive care many patients undergoing cancer treatment. purpose guidelines is to operationalize evaluation, prevention, treatment FN, CIT, CIA adult with nonmyeloid malignancies enable patient clinician...
Adverse pregnancy outcomes occur frequently in women with sickle cell disease (SCD) across the globe. In United States, Black experience disproportionately worse maternal health than all other racial groups. To better understand how social determinants of impact SCD morbidity, we used California's Department Health Care Access and Information data (1991-2019) to estimate cumulative incidence without SCD-adjusted for age, insurance status, Distressed Community Index (DCI) scores. pregnant...
Race and ethnicity are associated with risk of venous thromboembolism in population-based studies. Blacks/African Americans have a higher incidence, whereas Asians/Pacific Islanders Hispanics lower incidence compared non-Hispanic Whites. The impact race/ethnicity on the cancer-associated thrombosis (CAT), common complication patients malignancy, has not been well defined. Using California Cancer Registry linked to Patient Discharge Dataset Emergency Department Utilization database, we...
Abstract Bleeding is a known complication of sickle cell disease (SCD) and includes hemorrhagic stroke, hematuria, vitreous hemorrhage. However, the incidence bleeding events in patients with SCD has not been well described. We present retrospective, population-based study examining cumulative 6423 from 1991 to 2014. also studied risk factors associated effects on mortality, using Cox proportional hazards regression models. used California emergency department hospitalization databases...
Abstract Previous reports show increased incidence of venous thromboembolism [VTE, deep‐vein thrombosis (DVT) and pulmonary embolus (PE)] in sickle cell disease (SCD) patients. The incidence, time course, risk factors for VTE recurrence have been less well described. We determined the cumulative first bleeding a cohort SCD patients with incident VTE. Risk were also using multivariable Cox regression models, adjusting gender, race/ethnicity, era VTE, location hospitalization‐associated status...
The epidemiology of isolated distal deep venous thrombosis (iDDVT) among cancer patients is not well described, particularly the incidence recurrent thromboembolism (rVTE) and effect on mortality by type. cumulative (CI) iDDVT was determined for with 13 common cancers between 2005 2017 using California Cancer Registry linked to Patient Discharge Emergency Department Utilization datasets. CI rVTE calculated association incident cancer-associated (CT) location Cox proportional hazards...
Venous thromboembolism (VTE) and major bleeding in primary central nervous system lymphoma (PCNSL) patients are not well described. We identified 992 PCNSL using the California Cancer Registry (2005–2014). The cumulative incidence of VTE was determined hospitalization data. 12-month 13.6% (95% confidence interval (CI) 11.5–15.8%); chemotherapy radiation therapy were associated with increased risk (hazard ratio (HR) 2.41, CI 1.31–4.46 HR 1.56, 1.08–2.25, respectively). 12.4% (CI 10.1–14.6%)....
Summary Sickle cell disease ( SCD ) patients have a higher incidence of certain cancers, but no studies determined the impact cancer on survival among patients. n = 6423), identified from state‐wide hospitalisation data, were linked to California Cancer Registry (1988–2014). Multivariable Cox proportional hazards regression was used examine survival. Among patients, diagnosis associated with 3‐fold increased hazard death. Compared matched without , worse overall survival, not cancer‐specific...
The cumulative incidence, risk factors, rate of subsequent venous thromboembolism (VTE) and bleeding impact on mortality isolated upper extremity deep vein thrombosis (UE DVT) in acute leukemia are not well-described. California Cancer Registry, used to identify treated patients with myeloid (AML) lymphoblastic (ALL) diagnosed between 2009 2014, was linked the statewide hospitalization database determine incidences UE DVT VTE after diagnosis. Cox proportional hazards regression models were...
e18190 Background: Upper extremity deep venous thrombosis (UE DVT) is a known complication in patients with cancer. However, the cumulative incidence by cancer type, risk factors associated UE DVT and impact on survival not well-described. Methods: Using California Cancer Registry , we identified 10 common malignancies (2005-2014) linked this to hospitalization emergency department databases find an incident event using specific ICD-9-CM codes. We determined of adjusted for competing death....
We investigated the association of inferior vena cava filter (IVCF) usage with early mortality and intracranial hemorrhage (ICH) in patients cancer venous thromboembolism (VTE), without brain metastasis. used California Cancer Registry data linked to hospitalization emergency department databases identify (all ages) melanoma, kidney, breast or lung who had an acute VTE during 2005–2017 at hospital admission. Primary outcomes were 30-day 180-day ICH post-index hospitalization. Of 16,847 VTE,...